Moderna Therapeutics
Michael Lonetto is an accomplished professional with extensive experience in the pharmaceutical and biotech sectors. Currently serving as Associate Director and Product Owner at Moderna since October 2022, Michael is focused on reimagining clinical trial operations. Prior to this role, Michael spent a decade at Novartis Institutes for BioMedical Research, where responsibilities included managing a product team for a cloud-based data ecosystem and providing program management in support of translational medicine. Michael's earlier positions include roles at Merck, GlaxoSmithKline, and SmithKline Beecham, contributing significantly to genomics studies, clinical operations, and bioinformatics program management. Michael holds a PhD in Molecular Biology from the University of Wisconsin-Madison, an MS in Biology from Princeton University, and a BSc in Biology from Muhlenberg College.
This person is not in any teams
This person is not in any offices